Search Results 1041-1050 of 18599 for Influenza

  1. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    and up to 5 months after the last dose of atezolizumab. - Influenza vaccination should be given during influenza season only (approximately ... Patients must not ...

  2. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

    Influenza vaccination should be given during influenza season only (approximately October to March); patients must not receive live, attenuated influenza ...

  3. Reactive arthritis - Symptoms & causes - Mayo Clinic

    This joint pain is triggered by an infection in another part of the body — often the intestines, genitals or urinary tract.

  4. Abinash Virk, M.D. - Doctors and Medical Staff - Mayo Clinic

    MemberInfluenza Steering Committee, Clinical Practice Committee - Rochester. 2013 - present. MemberAntimicrobial Stewardship, Division of Infectious Diseases ...

  5. Muscle pain - Mayo Clinic

    Hypothyroidism: Should I take iodine supplements? Influenza (flu) · Infographic: Cancer Clinical Trials Offer Many Benefits · Jet lag disorder · Legionnaires ...

  6. Infectious diseases - Doctors and departments - Mayo Clinic

    Show more related content. News from Mayo Clinic. Mayo Clinic virologist offers perspective on avian influenza, bird flu, ...

  7. Rituximab (intravenous route) - Side effects & uses - Mayo Clinic

    Influenza Virus Vaccine, Live ... If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

  8. Featured News - Page 289 of 698

    Deb Balzer. February 24, 2020. Infectious Diseases A–Z: Influenza's second wave featured image. Infectious Diseases A–Z: Influenza's second wave. Deb Balzer.

  9. Pericarditis - Symptoms and causes - Mayo Clinic

    Stay up to date on the recommended vaccines, including those that protect against COVID-19, rubella and influenza. These are examples of viral diseases that ...

  10. Models for Cell Targeting - Virology, Vector and Vaccine Engineering: Michael A. Barry - Mayo Clinic Research

    Increasing or ablating immune responses; genetic vaccines versus HIV, influenza and biodefense agents. Ideal administration sites: intradermal, intranasal or ...